XONADINE

This brand name is authorized in Nigeria.

Active ingredients

The drug XONADINE contains one active pharmaceutical ingredient (API):

1
UNII 2S068B75ZU - FEXOFENADINE HYDROCHLORIDE
 

Fexofenadine is a non-sedating H1 antihistamine. Fexofenadine is a pharmacologically active metabolite of terfenadine.
 
Read more about Fexofenadine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-8122 Capsule Xonadine 120 mg CAP 120 mg 1 x 10's Capsule 03/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R06AX26 Fexofenadine R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-8122

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈